MaxCyte Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

MaxCyte heeft een totaal eigen vermogen van $221.3M en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $251.5M en $30.2M.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

US$0

Schuld

Rente dekkingsration/a
ContantUS$157.33m
AandelenUS$221.26m
Totaal verplichtingenUS$30.24m
Totaal activaUS$251.50m

Recente financiële gezondheidsupdates

Recent updates

MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 09
MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%

May 30
Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%

Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results

May 10
Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results

Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Mar 14
Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 07
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Oct 07
Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Aug 12
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

May 15
MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

May 14
Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Apr 27
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Nov 20
Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 02
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Nov 17
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

Jul 25
We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

Feb 22
MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $175.6M ) MXCT } overtreffen de korte termijn passiva ( $12.3M ).

Langlopende schulden: De kortetermijnactiva MXCT ( $175.6M ) overtreffen de langetermijnschulden ( $18.0M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: MXCT is schuldenvrij.

Schuld verminderen: MXCT had 5 jaar geleden geen schulden.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: MXCT heeft op basis van de huidige vrije kasstroom voldoende cash runway voor meer dan 3 jaar.

Voorspelling contante baan: MXCT heeft voldoende kasruimte voor meer dan 3 jaar als de vrije kasstroom blijft dalen met een historisch percentage van 22.5 % per jaar.


Ontdek gezonde bedrijven